Stock listing

Lang & Schwarz:A1158V Herantis Pharma PLC Aktie

German listing (Lang & Schwarz) of Herantis Pharma PLC · home listing Helsinki:HRTIS

Follow Herantis Pharma PLC into a list and get an email when it puts out news.

Home listing price · OMXHEX:HRTIS

€1.18 EUR -0.02 (-1.7%)

Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXHEX:HRTIS

Past year -47.1% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
€1.12 – €1.20 EUROct 30, 2026
Volume
64,380 sharesOct 30, 2026
Market cap
€31.27M EURAt the close on Oct 30, 2026 · price × 26.50M shares outstanding
52-week range
€1.12 – €2.87 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
€44,773 EURMedian day 24,134 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Herantis Pharma PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Helsinki:HRTIS · Home€1.18 EUR-0.02 (-1.7%)64,380€1.20€1.20€1.118€1.20Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXHEX:HRTIS · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.18-0.02-1.7%€1.20€1.20€1.11864,380
€1.20-0.034-2.8%€1.29€1.29€1.1727,832
€1.234-0.046-3.6%€1.26€1.26€1.23411,527
€1.28+0.114+9.8%€1.158€1.28€1.15841,785
€1.166+0.016+1.4%€1.138€1.174€1.1399,545
€1.15-0.076-6.2%€1.25€1.25€1.13250,997
€1.226-0.024-1.9%€1.248€1.248€1.2119,388
€1.25-0.016-1.3%€1.268€1.27€1.2513,091
€1.266-0.014-1.1%€1.33€1.33€1.2519,683
€1.28-0.016-1.2%€1.36€1.36€1.2714,249
€1.296-0.002-0.2%€1.296€1.298€1.2721,910
€1.298-0.062-4.6%€1.358€1.358€1.27437,796
€1.36+0.014+1.0%€1.36€1.37€1.34211,360
€1.346-0.016-1.2%€1.362€1.37€1.31634,236
€1.362+0.02+1.5%€1.342€1.362€1.33829,786
€1.342+0.004+0.3%€1.35€1.362€1.32812,773
€1.338-0.006-0.4%€1.42€1.42€1.3311,667
€1.344-0.056-4.0%€1.41€1.42€1.34411,859
€1.40+0.03+2.2%€1.372€1.40€1.34229,524
€1.37-0.048-3.4%€1.36€1.37€1.3241,046
€1.418+0.026+1.9%€1.392€1.428€1.34216,567
€1.392-0.03-2.1%€1.422€1.422€1.35819,043
€1.422+0.016+1.1%€1.38€1.428€1.3713,202
€1.406-0.02-1.4%€1.45€1.45€1.38211,750
€1.426+0.026+1.9%€1.40€1.448€1.37224,626
€1.400.000.0%€1.398€1.422€1.35426,860
€1.40+0.008+0.6%€1.398€1.40€1.3521,722
€1.392-0.008-0.6%€1.40€1.40€1.37221,941
€1.40+0.01+0.7%€1.404€1.41€1.3947,175
€1.39-0.01-0.7%€1.40€1.416€1.38418,696
€1.40+0.012+0.9%€1.392€1.41€1.3848,462
€1.388-0.022-1.6%€1.412€1.428€1.38434,905
€1.410.000.0%€1.412€1.412€1.3818,974
€1.41-0.02-1.4%€1.43€1.43€1.4060,102
€1.43-0.038-2.6%€1.458€1.462€1.42232,111
€1.468-0.01-0.7%€1.51€1.51€1.45414,196
€1.478-0.022-1.5%€1.50€1.522€1.45631,157
€1.50-0.03-2.0%€1.53€1.544€1.4660,971
€1.53-0.03-1.9%€1.56€1.582€1.52425,220
€1.56-0.036-2.3%€1.596€1.596€1.5426,407
€1.596+0.036+2.3%€1.56€1.598€1.5466,903
€1.56-0.002-0.1%€1.564€1.59€1.54212,308
€1.562-0.026-1.6%€1.57€1.586€1.5419,023
€1.588-0.048-2.9%€1.618€1.634€1.55413,973
€1.636-0.014-0.8%€1.65€1.66€1.62211,966
€1.65+0.03+1.9%€1.658€1.696€1.64820,408
€1.620.000.0%€1.638€1.68€1.6212,313
€1.62-0.07-4.1%€1.66€1.682€1.60624,590
€1.69+0.052+3.2%€1.652€1.69€1.65210,781
€1.638+0.106+6.9%€1.56€1.64€1.5627,497
€1.532+0.002+0.1%€1.592€1.626€1.53266,285
€1.53-0.16-9.5%€1.678€1.678€1.52687,493
€1.69-0.02-1.2%€1.702€1.708€1.65417,272
€1.71-0.068-3.8%€1.78€1.786€1.69424,609
€1.778-0.008-0.4%€1.78€1.786€1.72216,648
€1.786+0.026+1.5%€1.772€1.85€1.76248,372
€1.76+0.108+6.5%€1.68€1.762€1.689,067
€1.652-0.018-1.1%€1.692€1.716€1.6524,624
€1.67-0.042-2.5%€1.758€1.758€1.6438,294
€1.712+0.082+5.0%€1.652€1.792€1.652116,690
€1.63+0.07+4.5%€1.60€1.706€1.60118,566
€1.56+0.048+3.2%€1.558€1.606€1.5565,995
€1.512-0.036-2.3%€1.486€1.53€1.4420,591
€1.548-0.002-0.1%€1.552€1.56€1.5129,915
€1.55-0.01-0.6%€1.562€1.58€1.5024,134
€1.56+0.02+1.3%€1.54€1.632€1.50625,887
€1.54-0.048-3.0%€1.65€1.65€1.5332,531
Ticker
Lang & Schwarz:A1158V
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

Herantis Pharma Oyj to publish financial statements for the first half of 2026 on August 20, 2026 – invitation to webcast presentation

Aug 10, 2026

Closed €1.71 (+5.0%) on Aug 10, 2026

Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer

Jun 25, 2026

Closed €1.87 (+0.2%) on Jun 25, 2026

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096

Jun 2, 2026

Closed €2.27 (+2.0%) on Jun 2, 2026

Plc Annual Report 2025

Mar 30, 2026

Closed €1.62 (-2.1%) on Mar 30, 2026

Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

Mar 16, 2026

Closed €1.90 (+2.7%) on Mar 16, 2026

Herantis Pharma releases 2H and FY 2025 report today

Mar 5, 2026

Closed €2.03 (-2.4%) on Mar 5, 2026

Herantis Pharma Oyj to publish financial statements 2025 on 5 March 2026 – invitation to webcast presentation

Feb 23, 2026

Closed €2.15 (-0.5%) on Feb 23, 2026

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Feb 19, 2026

Closed €2.16 (-0.5%) on Feb 20, 2026

Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease

Jan 7, 2026

Closed €2.55 (+5.8%) on Jan 8, 2026

Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096

Nov 26, 2025

Closed €2.17 (+2.4%) on Nov 26, 2025

All Herantis Pharma PLC news

Decks

Herantis Pharma PLC on 6ix

Sector
Health care
Industry
Biotechnology
News releases
11 in the last 12 months · 17 in all · newest Aug 10, 2026 · oldest 2025
Decks
13 decks · latest September 2026

Where Herantis Pharma PLC is listed

ListingExchangeCountryCurrency
Helsinki:HRTIS · Home listingHelsinkiFinlandEUR
LS Exchange:A1158VLS ExchangeGermanyEUR
Lang & Schwarz:A1158V · This pageLang & SchwarzGermanyEUR

Log in to ask 6ix AI your own questions about Herantis Pharma PLC.